Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

COSTEM 2019

Transplantation

View all
1:57
Oral vs. intravenous busulfan pre-conditioning for HSCT
Marcos de Lima • 25 Oct 2019
2:06
Can CAR-T cells replace ASCT in DLBCL?
Michael Bishop • 25 Oct 2019
2:14
Mesenchymal stromal cells in the treatment of acute GVHD
Peter Bader • 25 Oct 2019
1:29
University of Chicago: the first certified CAR-T center in the US
Michael Bishop • 25 Oct 2019

GvHD

View all
3:36
Is endothelial protection effective for GVHD, VOD and TMA?
Mohamad Mohty • 26 Oct 2019
1:58
ASCT in the outpatient setting
Rainer Storb • 28 Oct 2019

MRD

View all
3:03
Improving AML outcomes
Charles Craddock • 26 Oct 2019
3:13
Is MRD monitoring prior to allograft standard in AML?
Michael Heuser • 25 Oct 2019

Multiple Myeloma

View all
2:01
The Chinese CAR-T experience
Peihua Lu • 25 Oct 2019
1:22
MM: stem cell mobilization regimens with and without plerixafor
Nicolaus Kröger • 25 Oct 2019

Lymphoma

View all
2:06
Can CAR-T cells replace ASCT in DLBCL?
Michael Bishop • 25 Oct 2019
2:01
The Chinese CAR-T experience
Peihua Lu • 25 Oct 2019

Leukemia

View all
2:45
Optimal preparative regimen for AML
Charles Craddock • 25 Oct 2019
3:07
How will CAR-T cells help us cure Ph+ ALL?
Peter Bader • 25 Oct 2019

Anemia

View all

Sorry, no posts matched your criteria.

The content of VJHemOnc is intended for healthcare professionals